Ascendis Phase III Data Gives TransCon PTH An Edge In Hypoparathyroidism

 
• By Jessica Merrill
  
Soccer Goal
A Phase III trial for Ascendis' drug was positive • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D